Icon

VAZCULEP (nda204300)- (10MG/ML (10MG/ML),50MG/5ML (10MG/ML),100MG/10ML (10MG/ML))

PHENYLEPHRINE HYDROCHLORIDE EXELA PHARMA
10MG/ML (10MG/ML),50MG/5ML (10MG/ML),100MG/10ML (10MG/ML)
No Yes
Expired Expired
None None
None No
VAZCULEP (phenylephrine hydrochloride) Injection is an alpha-1 adrenergic receptor agonist indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia.
15 0 13
Total Other Developers 13
Drugs with Suitability No
10MG/ML (10MG/ML) ** ** - - -
50MG/5ML (10MG/ML) ** ** - - -
100MG/10ML (10MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
No 11
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** ******** ************ ****** ***. *********** *** *** *****-***** ******, ************, ** *** ***, ****** (***) ***
****** ****** ****** *************** ******* ******* *********** ****** **. ***/*/*, *****, ******, *********, ******* ******, ***** (***) ***
****** ***** ****** *** ***** ****** ******* *********** **** **: **-**, **, **, **-**, **. **. ***, ***, *** & ***, ***** ***, *****, ************ *******, ********** ******, ********** ********, *********, ********* ******, ***** (***) ***
****** ****** ******** ***** *************** ******* *********** **** **. ***/***-****** / **** **.***/****-*********** , *******-***** ******* , ****** -******, ******, *********, ******* ******, ***** (***) ***
****** ****** ******** ***** *************** ******* *********** **** **. * ** **, *******, **** ******* ******, *******-***** *******, **. *-*, ****** ******, *********, ******* ******, ***** (***) ***
****** ****** ****** ******** ******* *********** ****** **.*** & ***. ******************, **************** (****), *********** (********), *************, ***** **** ******, ***** (***) ***
****** ******* ****** ******* ****** ******* *********** ****-***, ******* *****, ****** **** ****, ***. ****** *******, ****** *****, *******, ******** ******* ******, ***** (***) ***
****** ****** **** ****** **** *****. **., ***. *********** ********** ******** *********** ****, ****** ********, ******, ****** ******, ***** (***) ***
****** ******** ******* ****-****** *********** ************** **.,***. (*** ****) *********** **, ** ***** ****, ******* **** *** *** ********** *********** **** ******* ******, *******, ******* ******, ***** (***) ***
****** ********* **** *** ********* **** ***, *** *********** **** *. **** ****** **** ***** ********* ******, ******* ****, ******** (**) *****, ****** ****** (***) ***
****** ********* **** *** ********* **** ***, *** *********** **** *. ******* ****** **** ***** ********* ******, ******* ****, ******** (**) *****, ****** ****** (***) ***
****** ***** ****** ***** ****** ************ ******* *********** ****-***, **** **: *, ** ** **, ****, *****, ***, ************, ********** ******, **********, ********* ******, ***** (***) ***
****** ****** ****** *************** ******* ******* *********** **** ** ** & **, ******* ******* ******** **** *******-***** *.*. **. **, ***.: ******, ***.: ******, *********, ** ******, ***** (***) ***
****** ****** ****** *************** ******* ******* *********** **** **. **, ******* ******* ******** **** *******-***** *.*. **. **, ***.: ******, ***. ******, *********, ** ******, ***** (***) ***
****** ****** ****** *************** ******* ******* *********** ****** **. ***/*/*, *****, ******, *********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.